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Development status of typhoid conjugate
vaccines globally
S. Sahastrabuddhe
International Vaccine Institute, Seoul, Korea,
Republic of
Abstract: Salmonella Typhi, the bacteria that causes Typhoid
fever, is one of the ﬁrst bacterium cultured and isolated. This
scourge still affects many children and adults mainly in the poor
communities in the developing countries. There are currently two
moderately efﬁcacious typhoid vaccines that are licensed in many
countries and one of themhas been prequaliﬁed byWHO, but there
are limitations to these vaccines in terms of storage conditions, age
of administration and need for revaccination because of limited
efﬁcacy. There are new vaccine candidates in the pipeline using
conjugation technology or recombinant DNA technology. Two of
these conjugate vaccines are available in India and although the
data is still unclear about their effectiveness, they should be uti-
lized to better control the disease. In this presentation, we will get
updates on the current status of vaccine development for various
typhoid conjugate vaccines and ways forward.
http://dx.doi.org/10.1016/j.ijid.2016.02.188
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Strategies on containing and treating drug
resistant typhoid in low and middle-income
contries
A. Arjyal
Oxford University Clinical Research Unit, Lalitpur,
Nepal
Abstract: Multiple strategies for the patient and clinician, and
for the population and policymakers should be urgently schemed
to counter drug resistant enteric fever in LMICs.
The usual patient-clinician interface, a single meeting at the
point of care, with one or two follow-ups afterwards, should be
extended both retrospectively and prospectively. Retrospectively,
with a careful screening and documentation of putative expo-
sures in the probable incubation period, and prospectively, with a
post-treatment tracing of close contacts for features of illness and
monitoring of the patient for relapse or treatment failure. Where
blood-culture is available, pairing of clinical data with suscepti-
bility data should be carried out. All this information should be
notiﬁed to an empowered local public health body so that pre-
ventive measures may be instituted promptly. Clinicians and other
team-members involvedmustbe rewarded forpreventionandcon-
trol efforts.
Promulgation of current diagnosis and treatment guidelines,
readily accessible and implementable with local resources, should
be carriedout routinely. This shouldbebasedona constant pipeline
of treatment studies, preferably randomised controlled trials, con-
ducted in an area with a similar susceptibility pattern. As an
example, the ﬂuoroquinolones, drugs of choice until quite recently,
shouldn’t beused inmostof SouthAsia,where there is awidespread
circulation of fully resistant strains, and agencies such as the WHO
should promptly endorse a fact as such.
Notiﬁcation and guideline access should exploit thewidespread
availability of web resources and mobile communications.
The development of rapid diagnostic tests must be prioritized
and the way must be paved for the discovery and production of
newer antimicrobials and rediscovery and reuse of older agents
hitherto no longer in use. Awareness about antibiotics should be
increased and stringent controls over antibiotic use should be exer-
cised. Vaccination, even if it bewith the existing Vi polysachharide,
despite its limited efﬁcacy or highmarket prices, can be carried out
selectively in populations, age groups or geographic areas at a high
risk of disease.
Theprovisionofhygiene, sanitationandsafedrinkingwatermay
need tremendous investments in infrastructure and can be very
difﬁcult to attain in a short span of time. Until such a time, given
the high costs of resistant disease to the individual and society, the
additional strategic steps to contain it outlined above are deﬁnitely
worth the extra endeavours.
http://dx.doi.org/10.1016/j.ijid.2016.02.189
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Global typhoid policy recommendations
A. Zaidi
Bill & Melinda Gates Foundation, Seattle, WA, USA
Abstract: The burden of typhoid is signiﬁcant and occurs largely
in children, with the highest rates occurring in children under
5 years of age living in poor urban environments in South Asia
and sub-Saharan Africa. Water scarcity, climate change, and rapid
uncontrolledurbanization in lowand low-middle incomecountries
may mitigate any improvements in water, sanitation and hygiene
infrastructure historically seen with socio-economic development,
and lead to conditions favoring more typhoid transmission in the
future. In addition, the alarming increases in antibiotic resistance
and theemergenceof agloballypervasiveanddominantmulti-drug
resistant strain (H58) seriously limits the oral therapeutic options
available and has the potential to drive increased burden and case
fatality.
Despite the substantial burden and the high probability that
effective typhoid conjugate vaccines (TCVs) will be available in
the near future, there has been a lack of global momentum for
achieving typhoid control. In order to align the global commu-
nity towards concerted action on typhoid, an aggressive goal for
global typhoid control, and an action plan is needed. We believe
aggressive typhoid control is achievable through an integrated
approach including improving surveillance systems to accurately
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measure disease burden, accelerating the introduction of TCVs in
endemic areas, and incorporating water, sanitation, and hygiene
systems improvements. The adoption of the Sustainable Develop-
ment Goals presents an opportunity to drive this multi-sectoral
approach, addressing the interconnected issues of poverty, clean
water and sanitation, urbanization, and health. This is a high lever-
age opportunity for the global community to drive an intensive
typhoid control strategy and impact this signiﬁcant public health
problem.
http://dx.doi.org/10.1016/j.ijid.2016.02.190
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Protecting the healthcare worker around the
world
R. Gallagher
Royal College of Nursing, London, United Kingdom
Abstract: The protection of healthcare workers is central to
the success and delivery of health and social care and public
health strategies globally. Healthcare workers are positioned at
the interface between the patient (or population) and interven-
tions to improve health and can be exposed to different risks
depending on their role and health setting including biological
(micro-organisms), chemical, physical and radiological. The level
of risk may also vary from country to country. Healthcare workers
are expensive to educate and train and the chronic global short-
age of doctors, nurses and midwives is exacerbated when staff
are lost through avoidable exposure to risks that damage their
health andpotential ability towork. The costs ofmaking reasonable
adjustments to retain employees who develop health conditions
or disabilities is acknowledged to be lower than costs of recruit-
ing and training new staff (Faculty of Public Health 2006). This
presentation will explore a range of risks that exists in different
care settings where lessons and learning has been identiﬁed. Sci-
entiﬁc and professional organisations both share responsibilities
and accountability for success in protectinghealthcareworkers and
need to work together to achieve this aim. This presentation will
share learning and the experience of the Royal College of Nursing
(a UK based professional nursing organisation) and its relation-
ships with European and wider global stakeholders through its
work to improve the protection and safety of healthcare workers.
The success of campaigns to highlight risks of sharps injuries and
subsequent introduction of legislationwill be speciﬁcally explored.
http://dx.doi.org/10.1016/j.ijid.2016.02.191
Type: Invited Presentation
Final Abstract Number: 39.002
Session: Protecting the Healthcare Worker Around the World
Date: Saturday, March 5, 2016
Time: 15:45-17:45
Room: Hall 6
Technologies for hospital disinfection and
textiles for bioburden reduction
G. Bearman
Virginia Commonwealth University, Richmond, VA,
USA
Abstract: Reduction of microbial contamination of the hospital
environment is a challenge yet has potential impacts on infection
prevention efforts. This lecture will explore the potential role of
new technologies to limit bioburden on inanimate surfaces and
healthcare worker uniforms. The literature on new technologies
such as antimicrobial textiles, hydrogen peroxide and UV light-
based decontamination systems for cleaning of hospital rooms will
be explored. Knowledge gaps on cleaning of hospital surfaces are
summarized and the application of these technologies as part of a
horizontal infection prevention platform will be discussed.
http://dx.doi.org/10.1016/j.ijid.2016.02.192
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The impact of education on reducing Ebola virus
disease transmission in healthcare facilities
S. Mehtar
Stellenbosch University, Cape Town, South Africa
Abstract: Background: The largest Ebola outbreak in history
occurred between Dec 2013 and October 2015, in Sierra Leone,
Liberia and Guinea- a total of 28640 cases with 11 315 deaths
(39.5%) were recorded. Amongst healthcareworkers (HCW), a total
of 881 cases with 531 deaths was recorded until the end of Dec
2015. The strategic plans included strengthening of healthcare sys-
tems, infection control (IC) training of as many (HCW) as possible,
and establishing a national IC programme.
Training: ICAN is the largest IPC organisation in Africa with a
high level expertise in IPC. In collaborationwith theWHO and CDC,
ICAN delivered the main IC training in Sierra Leone. A one week
Basic IPC course on containing Ebola was prepared. The course was
structured to provide formal lectures but mainly to engage the stu-
dents in problem solving, group discussion and peer-presentations
to assess their ability to teach others.
Results: In total, 215 HCW were trained in three batches over
9 months with an overall pass rate of 93%. Challenges highlighted
during the early days of the EVD outbreak was confusion, not only
among the HCW but also the tutors; fear of the unknown and non-
evidence based rituals were introduced and perpetuated- some,
like spraying humanswith chlorine, were dangerous. The impact of
